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Purpose: Impending central retinal vein occlusion is associated with mild or no loss of vision; however, its progress 
and vision prognosis have not been clearly defined until now.  Therefore, we studied the progress and prognoses 
in patients with impending central retinal vein occlusion. 
Methods: For this study, we selected ten subjects who had been diagnosed with impending central retinal vein oc-
clusion, and we retrospectively reviewed their progress and prognoses.   
Results: The average age of the subjects was 31.0 years (18 to 48 years).  Eight patients were male and two were 
female.  The average observational period was 5.5 months.  Six out of ten subjects were found to have no under-
lying systemic disease, four subjects had underlying disease.  All ten patients were affected unilaterally.  When 
initially tested, the affected eyes showed an average vision of LogMar 0.30.  The final vision test revealed an 
average of LogMar 0.04, which indicates good progress and prognosis.  In one patient, retinal hemorrhage and 
macular edema progressively worsened after the diagnosis, and the patient was treated with radial optic 
neurotomy. 
Conclusions: The cases of impending central retinal vein occlusion that we observed seemed to primarily affect 
young patients with generally good prognoses. However, in some cases, the degrees of obstruction and hemor-
rhage increased as time progressed.  This suggests that impending central retinal vein occlusion could develop 
into the prodromal phase of an acute attack. 
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Central retinal vein occlusion mainly affects people over 
60 years of age, and it can cause loss of vision due to retinal 
hemorrhage [1-2]. Many classifications of central retinal 
vein occlusion have been published, but the most noticeable 
report was published by Magargal et al. [3] in 1982. They 
classified central retinal vein occlusion into ischemic, 
non-ischemic, and intermediate. Later, Gass created a new 
classification of impending central retinal vein occlusion, 
which has little or no loss of vision [4]. However, the prog-
ress and prognosis of vision for impending central retinal 
vein occlusion has not been reported. Therefore, we per-
formed this study on the natural progress and visual prog-
nosis of impending central retinal vein occlusion. 
Materials and Methods
We selected patients who were diagnosed with impending 
central retinal vein occlusion from January 2003 to March 
2007 in Wonju Christian Hospital, and we retrospectively 
studied their medical records. By Gass’ definition, impend-
ing central retinal vein occlusion has mild or no loss of vision 
with venodilation and retinal dot hemorrhages under fundus 
examination [4].  In all patients, slitlamp examination, intra-
ocular pressure, gonioscopy, refraction, visual field, fundu-
scopy, and fluorescein angiography were performed as part of 
a physical examination. To determine any underlying systemic 
disease, blood test, neurologic examination including brain 
computed tomography scan, carotid artery ultrasonography, 
cardiovascular examination including blood pressure meas-
urement, and electrocardiography were performed.
Results
In ten patients with impending central retinal vein occlu-Korean J Ophthalmol Vol.24, No.2, 2010
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Table 1. The profiles of the patients
Case Age/
Sex
Past medical
history
Symptoms Vision on initial 
exam.
(LogMar)
IOP
(mmHg)
ME/
DE
Surgery Recovery 
time
(mon)
Vision on last 
exam.
(LogMar)
Follow up 
period
(mon)
12 6 / M ‐ Cloudiness
of vision
0.1 Normal
range
‐/‐‐ 10 . 04
23 2 / F ‐ Black‐out
of vision
0.0 Normal
range
‐/‐‐ 20 . 04
31 8 / M ‐ Black‐out
of vision
0.2 Normal
range
‐/‐‐ 10 . 01
4 32/M Old pulmonary 
tuberculosis
Cloudiness
of vision
0.4 Normal
range
‐/‐‐ 10 . 0 1 6
5 48/F Hypotension Visual 
impairment
1.0 Normal
range
‐/‐‐ 10 . 03
63 1 / M ‐ Cloudiness
of vision
0.2 Normal
range
‐/‐‐ 20 . 0 1 2
7 26/M Hypertension Cloudiness
of vision
0.2 Normal
range
‐/‐‐ 10 . 04
83 9 / M ‐ Cloudiness
of vision
0.6 Normal
range
+/‐ TPPV, RON, 
IVTA
60 . 29
9 38/M Bronchiolitis Transient 
visual loss
0.1 Normal
range
+/+ ‐‐ 0.2 0.5
10 20/M ‐ Transient 
visual loss
0.2 Normal
range
‐/‐‐ 10 . 01
Average 31.0±9.1 0.30 1.78±1.6 0.04 5.5±5.1
IOP=intraocular pressure; ME=macular edema; DE=disc edema; TPPV=trans pars plana vitrectomy; RON=radial optic neurotomy; IVTA=
intravitreal triamcinolone injection.
sion, eight were male (80%) and two were female (20%). The 
age distribution was between 18 and 48 years, with impend-
ing central retinal vein occlusion usually affecting a rela-
tively young age group averaging 31.0±9.1 years of age. All 
ten subjects were affected unilaterally. The ocular pressures 
in all subjects were found to be normal. On fundus examina-
tion, mild venous dilation and retinal hemorrhage were 
observed. The initial vision for the affected eyes was LogMar 
0.30, and the final vision was LogMar 0.04. Eight out of ten 
patients showed good visual progress (Table 1). 
The average recovery time was 1.8 months. Two subjects 
showed worsening of symptoms during the study period. 
One case had progressed to central retinal vein occlusion, 
and after treatment with vitrectomy, radial optic neurotomy 
and intravitreal injection of triamcinolone, the patient’s vi-
sion improved. The other patient was not treated due to the 
short follow-up period. Four patients had hypotension, hy-
pertension, pulmonary tuberculosis, and bronchiolitis, 
respectively. The other six patients had no specific systemic 
disease and no abnormalities on neurologic examination.
Case 3
An 18-year-old male patient with no specific history was 
admitted due to complaints of amaurosis fugax in his left eye. 
Blood test and neurologic exam did not reveal any 
abnormality. The initial LogMar vision was 0.2. On fundus 
examination, venous tortuosity and dilation in the central ret-
inal vein were found. He was followed for one month without 
any particular treatment. The LogMar vision after one month 
was improved to 0.0, and venous tortuosity and congestion in 
the central retinal vein disappeared completely (Fig 1). 
Case 6 
A 31-year-old male patient with complaints of mild vision 
loss in his left eye visited the hospital. No specific history 
was discovered. Blood test and neurologic examination 
showed no specific finding. The initial vision was LogMar 
0.2, and on fundus examination, venous tortuosity, venous di-
lation, dot hemorrhages, and cotton-wool spots were 
observed. The patient was followed for two months without 
treatment, after which his vision improved to 0.0 and the pre-
viously observed central vein and retinal lesions improved 
(Fig 2). 
Case 8 
A 39-year-old male patient without any specific history 
visited the hospital with the chief complaint of vision loss in 
his right eye. The initial vision was LogMar 0.6. Under fun-
dus examination, venous tortuisity, dilation, and retinal h
emorrhages were observed. After two weeks of admission, 
the retinal hemorrhage was aggravated, and the vision was 
down to LogMar 1.0. The patient was treated with vi-
trectomy, radial optic neurotomy and intravitreal injection of 
triamcinolone. After two weeks of treatment, the retinal hem-
orrhage improved. After six months, the retinal hemorrhage 
subsided (Fig 3). The retinal venous tortuisity and dilation in 
the central retinal vein improved, and the LogMar vision also DH Lee, et al. Clinical progress of Impending CRVO
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Fig. 1. Case 3. (A) Fundus findings of slightly tortuous and engorged retinal veins at first visit. (B) After one month, the retinal venous tortuos-
ity and engorgement were no longer present. 
A B
Fig. 2. Case 6. (A) Fundus findings of flame-shaped retinal hemorrhage, moderated retinal venous engorgement, cotton-wool spots and dot 
hemorrhage at first visit. (B) After two months, the fundus returned to its normal appearance.
improved to 0.2. 
Case 9
A 38-year-old male patient with a history of bronchiolitis 
visited the hospital due to vision loss in the right eye. The ini-
tial LogMar vision was 0.1. On fundus examination, papil-
ledema was discovered together with retinal venous tortui-
sity, dilation, and retinal dot hemorrhages in central retinal 
vein occlusion. The patient was followed without specific 
treatment. Two weeks after the visit, the vision was ag-
gravated to 0.2, with macular edema and papilledema (Fig 4). 
Discussion
Central retinal vein occlusion has a wide range of manifes-
tations, from mild and sporadic retinal hemorrhage to vitre-
ous hemorrhage. Since Leber [5] first described the clinical Korean J Ophthalmol Vol.24, No.2, 2010
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Fig. 3. Case 8. (A) Fundus findings of some dot retinal hemorrhages and moderated retinal venous engorgement at first visit. (B) After two 
weeks, the flame-shaped retinal hemorrhages and vascular tortuosity increased. Vitrectomy, radical optic neurotomy and intravitreal tri-
amcinolone injection were performed. (C) Two weeks after radial optic neurotomy, retinal hemorrhage and tortuosity decreased. (D) After six 
months, the fundus returned to its normal appearance.                 
manifestation of central retinal vein occlusion as retinal apo-
plexy in 1854, scholars have suggested multiple classi-
fications of the disease. Hayreh et al. [6] classified central 
retinal vein obstruction into two categories, venous stasis ret-
inopathy and hemorrhagic retinopathy. Venous stasis retin-
opathy is a mild form without central retinal vein occlusion, 
and hemorrhagic retinopathy is a severe form with central 
retinal vein occlusion. The two different types have a differ-
ent fundus finding, clinical manifestation and prognosis [6]. 
Magargal et al. [3] added an intermediate category into the 
original classification of Hayreh et al. and at the same time 
classified it into three types based on ischemic and hyper-
permeable conditions. Gass et al. [4] reported impending or 
incipient central retinal vein occlusion. By Gass’ definition, 
impending central retinal vein occlusion has no or mild loss 
of vision with venodilation and retinal dot hemorrhage under 
fundus examination [4]. This condition has also been defined 
as a lesion with transient vision loss [4]. Gass et al. [4] con-DH Lee, et al. Clinical progress of Impending CRVO
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Fig. 4. Case 9. (A) Fundus findings of retinal dot hemorrhages, enlarged retinal vein and mild disc swelling at first visit. (B) After two weeks, 
the disc swelling and macular edema worsened and a hard exudation appeared at the posterior pole. 
sidered impending central retinal vein occlusion as a risk fac-
tor for the development of central retinal vein occlusion. 
However, no confirmed theory has been published regarding 
the natural progress of impending central retinal vein 
occlusion. 
Mancall [7] suggested that in the case of central retinal 
vein occlusion, the left eye is more frequently involved in 
males. However, Raitta [8] reported no discrepancies be-
tween left and right involvement or in male and female 
prevalence. In this study, we found that impending central 
retinal vein occlusion is more prevalent in males. No differ-
ence in prevalence was found between the left and right eyes.
Factors known to cause central retinal vein occlusion in-
clude hypertension, diabetes mellitus, atherosclerosis, hyper-
lipidemia and primary open angle glaucoma [1]. Zegarra et 
al. [9] reported that hypertension, atherosclerosis and dia-
betes mellitus accompany central retinal vein occlusion in 
57%, 34%, and 34% of cases, respectively. Other studies have 
discovered that hematologic disease, paraproteinemia, vas-
culitis, and autoimmune disease accompanying changes in 
coagulation mechanism and viscosity of blood are often as-
sociated with central retinal vein occlusion [10-13]. In our 
study, four patients had systemic disease including hyper-
tension, hypotenstion, bronchiolitis and pulmonary tuberculosis. 
Hypertension, diabetes mellitus, hyperlipidemia, and other 
factors are relatively less associated with the occurrence of 
central retinal vein occlusion than they are with increased 
age [14]. Most of our patients were rather young, so they did 
not have general systemic risk factors of central retinal vein 
occlusion, except for hypertension.
Central retinal vein occlusion in young individuals usually 
has a good prognosis and a decreased risk for serious vision 
loss. In this study, we found that most patients recovered 
without any specific treatment, with only two patients devel-
oping aggravated disease. In the case of one patient, treat-
ment with vitrectomy, radial optic neurotomy, and intra-
vitreal injection of triamcinolone improved the condition. 
We conclude that most cases of impending central retinal 
vein occlusion have a good prognosis. On the other hand, we 
found that the disease can advance to the prodromal phase of 
central retinal vein occlusion with intensifying obstruction 
and hemorrhages. Therefore, it appears that this disease may 
have the potential for bidirectional progress. 
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